Abbvie Fair Value
AB
The fair market value of ABBV stock is 76.3 USD. Relative to the market price of 171.785 USD Abbvie is overvalued by 55.6%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Abbvie Valuation
Current ABBV share ticker price is 171.785 USD.
The fair value level of 76.3 USD can be considered as an effective entry point for long-term investors to start investing in ABBV stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 56% higher its fair value
Current price is 68% higher its minimum value
Current price is 7% higher its maximum value
Market price:
ABBV stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
Abbvie Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
55.48
2
Median P/E over 5 years
26.54
3
Minimum P/E over 5 years
19.33
4
Earning per share (last 12 months)
2.88 USD
Maximum value
1
x
4
=
159.52 USD
Fair value
2
x
4
=
76.3 USD
Minimum value
3
x
4
=
55.58 USD
Abbvie Inc price metrics
13.23
Annual return (geometric mean)
24.95
Risk (standard deviation) of returns
β
0.57
Beta (volatility compared to market)